宏源药业：第三季度净利润471.03万元，同比增长1316.05%

Core Viewpoint - Hongyuan Pharmaceutical reported a revenue of 435 million yuan for Q3 2025, representing a year-on-year increase of 2.45%, while net profit reached 4.71 million yuan, showing a significant year-on-year growth of 1316.05% [1] Financial Performance - For the first three quarters, the company generated a revenue of 1.317 billion yuan, which is a slight decline of 0.39% year-on-year [1] - The net profit for the first three quarters was a loss of 1.1 million yuan, marking a substantial year-on-year decrease of 103.04% [1]